Ownership history in Ghost Tree Capital, LLC · 32 quarters on record
This page tracks every 13F SEC filing in which Ghost Tree Capital, LLC reported a position in ASCENDIS PHARMA A S (ASND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | REDUCED | 52,500 | -34,221 | -39.5% | 2.37% | $7.8M | $149.31 |
| 2024 Q2 | ADDED | 86,721 | +66,721 | +333.6% | 3.70% | $11.8M | $136.38 |
| 2023 Q4 | REDUCED | 20,000 | -65,000 | -76.5% | 0.82% | $2.5M | $125.95 |
| 2023 Q3 | REDUCED | 85,000 | -15,000 | -15.0% | 2.62% | $8.0M | $93.64 |
| 2023 Q2 | REDUCED | 100,000 | -10,000 | -9.1% | 2.95% | $8.9M | $89.25 |
| 2023 Q1 | REDUCED | 110,000 | -20,000 | -15.4% | 3.49% | $11.8M | $107.22 |
| 2022 Q4 | ADDED | 130,000 | +35,000 | +36.8% | 6.78% | $15.9M | $122.13 |
| 2022 Q3 | ADDED | 95,000 | +20,000 | +26.7% | 2.75% | $9.8M | $103.26 |
| 2022 Q2 | REDUCED | 75,000 | -65,000 | -46.4% | 3.63% | $7.0M | $92.96 |
| 2022 Q1 | REDUCED | 140,000 | -50,000 | -26.3% | 3.57% | $16.4M | $117.36 |
As of 2025 Q4 — sorted by position size